GLOBEALERT
SCI & TECH● LOW1h ago · Oct 15, 2026, 9:07 PM

Anavex Life Sciences gains IND clearance for blarcamesine in Fragile X syndrome

Seeking Alpha Tech · global

Anavex Life Sciences has received IND clearance for blarcamesine as a treatment for Fragile X syndrome. This marks a step forward in the development of a potential new therapy for the condition.

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.

More in Sci & Tech